Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

Bench to Bedside

CMAJ February 28, 2006 174 (5) 610; DOI: https://doi.org/10.1503/cmaj.060079
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Polymer hints at new clotting agent

A molecule once studied exclusively in simple cellular organisms has been recently shown to play an important role in the ability of human platelets to clot. Polyphosphate, a polymer of inorganic phosphate, is widely found in nature and was discovered over a decade ago in bacteria, fungi and yeast, where it was found to be involved in virulence and stress responses.

Figure

Figure. Photo by: National Cancer Institute

In bacteria, polyphosphates are housed in acidocalcisomes. In humans, platelets were recently discovered to contain granules that strongly resemble acidocalcisomes and contain polyphosphate (J Biol Chem 2004;279:44250-7). Furthermore, people with defects in the dense granules of their platelets can display bleeding disorders, a discovery that led Stephanie Smith and colleagues to look into the role of polyphosphate in blood clotting. In a model using human plasma in vitro, they found that the addition of polyphosphate decreased clotting time from 25 minutes to less than 5 minutes, and extended the time until clots lysed (fibrinolysis) by over 20 minutes (Proc Natl Acad Sci USA 2006;103:903-8).

Polyphosphate appears able to enhance coagulation on several levels: It activates components involved in the clotting cascade and enhances the work of an inhibitor of fibrinolysis called thrombin-activatable fibrinolysis inhibitor (TAFI). Furthermore, platelets secrete polyphosphate upon activation, which Smith and colleagues suggest could be important after vascular injury, since it would accelerate blood clotting.

With this newly discovered function of polyphosphate, its interest broadens beyond its role in basic biology. Indeed, Smith and colleagues are already envisioning polyphosphate as an additive one day in topical agents that control bleeding.

Imaging transplanted islet cells

Islet cell transplantation, a promising new way to treat type 1 diabetes, may someday obviate the need for exogenous insulin therapy. The ability to image transplanted cells would facilitate ongoing monitoring of both the cells and the patients who receive them.

Acquiring pictures of pancreatic β cells to assess their survival and improve transplant rates has been a focus in this field. Images of cells in islet grafts have successfully been made in the laboratory, for example by rendering the cells bioluminescent (Transplantation 2005;79:768-76). However, such techniques are not yet applicable in humans.

Natalia Evgenov and colleagues recently showed that it is possible to label transplanted islet cells with magnetic nanoparticles detectable by MRI (Nature Med 2006;12:144-8). They transplanted these tagged cells into mice and found that images of the cells could be made for up to 188 days afterward. The process did not alter the cell's insulin-secreting ability: normoglycemia was restored in the diabetic mice that received the transplanted cells.

The authors concluded that the tagging of islet cells could be useful in clinical practice to help evaluate graft survival and, during graft rejection, to monitor the response to therapies. — Compiled by David Secko, Vancouver

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 174 (5)
CMAJ
Vol. 174, Issue 5
28 Feb 2006
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bench to Bedside
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Bench to Bedside
CMAJ Feb 2006, 174 (5) 610; DOI: 10.1503/cmaj.060079

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Bench to Bedside
CMAJ Feb 2006, 174 (5) 610; DOI: 10.1503/cmaj.060079
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Is one-way masking enough?
  • XE, XD & XF: what to know about the Omicron hybrid variants
  • 5 infectious disease topics to watch
Show more News

Similar Articles

Collections

  • Topics
    • Hematology & transfusion medicine
    • Pathology

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire